Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: Is radiotherapy necessary after D2-dissection?
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (36) , 12900-12907
Abstract
Studies from the Far East have demonstrated that D2-dissection is superior to D0/1-dissection. The effect of postoperative chemoradiotherapy (CRT) after D2-dissection has not been accepted due to the lack of D2-dissection in Western countries, as well as the potential harmful effect of radiotherapy. In the current NCCN guideline, adjuvant chemotherapy alone is recommended in D2-dissected patients. However, three recent prospective randomized controlled trials in South Korea and China (ARTIST, NCC and Multicenter IMRT Trials) demonstrated that adjuvant CRT can be safely administered to D2-dissected patients with notable benefits. To identify the role of radiotherapy (RT) in the D2-dissected postoperative setting, clinical research attempts should include (1) identification of high-risk patients for loco-regional recurrence who might benefit from CRT; (2) modification of RT target volume based on the findings that failure patterns should be different after D1- and D2-dissection; and (3) integration of new RT techniques to decrease treatment-related toxicity. The present paper is a review of recent studies addressing these fields. Well-designed prospective randomized studies are needed to clearly define the role of adjuvant CRT in D2-dissected gastric cancer, however, future clinical studies should also focus on answering these questions.Keywords
This publication has 39 references indexed in Scilit:
- Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus RadiationThe Oncologist, 2013
- Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineationRadiotherapy and Oncology, 2013
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric CancerJournal of Clinical Oncology, 2010
- CT and PET in Stomach Cancer: Preoperative Staging and Monitoring of Response to TherapyRadioGraphics, 2006
- An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomachInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501Journal of Clinical Oncology, 2004
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trialBritish Journal of Cancer, 1999
- Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) — report on 370 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trialThe Lancet, 1996